Indication
Idiopathic Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis pipeline: 3 tracked drugs, 3 approved for this indication.
3 approved / phase 4
Total attributable cost
$8.8B
$56,004/patient
Drug spend
Not yet sourced
any · US
Indication
The Idiopathic Pulmonary Fibrosis pipeline: 3 tracked drugs, 3 approved for this indication.
Total attributable cost
$8.8B
$56,004/patient
Drug spend
Not yet sourced
any · US